[Federal Register Volume 86, Number 2 (Tuesday, January 5, 2021)]
[Notices]
[Pages 315-316]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-29141]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Advisory Council on Alzheimer's Research, Care, and Services; 
Meeting

AGENCY: Assistant Secretary for Planning and Evaluation, HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces the public meeting of the Advisory 
Council on Alzheimer's Research, Care, and Services (Advisory Council). 
The Advisory Council provides advice on how to prevent or reduce the 
burden of Alzheimer's disease and related dementias on people with the 
disease and their caregivers. During the January 25, 2021 meeting the 
Advisory Council will hear presentations on the impact of COVID-19 on 
people with dementia, health disparities in dementia research, and the 
implications of new technologies to identify Alzheimer's disease 
through a blood tests.

DATES: The meeting will be held on January 25, 2021 from 1:00 p.m. to 
4:30 p.m. EST.

ADDRESSES: The meeting will be virtual, streaming at http://www.hhs.gov/live.
    Comments: Time is allocated on the agenda to hear public comments 
from 4:00 p.m. to 4:30 p.m. The time for oral comments will be limited 
to two (2) minutes per individual. In order to provide a public 
comment, please register by emailing your name to <a href="/cdn-cgi/l/email-protection#83ede2f3e2c3ebebf0ade4ecf5"><span class="__cf_email__" data-cfemail="533d322332133b3b207d343c25">[email protected]</span></a> by 
Thursday, January 21. Registered commenters will receive both a dial-in 
number and a link to join the meeting virtually; individuals will have 
the choice to either join virtually via the link, or to call in only by 
using the dial-in number. Note: There may be a 30-45 second delay in 
the livestream video presentation of the conference. For this reason, 
if you have pre-registered to submit a public comment, it is important 
to connect to the meeting by 3:45 p.m. to ensure that you do not miss 
your name and allotted time when called. If you miss your name and 
allotted time to speak, you may not be able to make your public 
comment. All participant audio lines will be muted for the duration of 
the meeting and only unmuted by the Host at the time of the 
participant's public comment. Should you have questions during the 
session email <a href="/cdn-cgi/l/email-protection#a6c8c7d6c7e6ceced588c1c9d0"><span class="__cf_email__" data-cfemail="bfd1decfdeffd7d7cc91d8d0c9">[email protected]</span></a> and someone will respond to your message as 
quickly as possible.
    In order to ensure accuracy, please submit a written copy of oral 
comments for the record by emailing <a href="/cdn-cgi/l/email-protection#452b243524052d2d366b222a33"><span class="__cf_email__" data-cfemail="412f203120012929326f262e37">[email protected]</span></a> by Tuesday, January 
26. These comments will be shared on the website and reflected in the 
meeting minutes.
    In lieu of oral comments, formal written comments may be submitted 
for the record by Tuesday, January 26 to Helen Lamont, Ph.D., OASPE, 
200 Independence Avenue SW, Room 424E, Washington, DC 20201. Comments 
may also be sent to <a href="/cdn-cgi/l/email-protection#3a545b4a5b7a525249145d554c"><span class="__cf_email__" data-cfemail="ec828d9c8dac84849fc28b839a">[email protected]</span></a>. Those submitting written comments 
should identify themselves and any relevant organizational 
affiliations.

FOR FURTHER INFORMATION CONTACT:  Helen Lamont, 202-260-6075, 
<a href="/cdn-cgi/l/email-protection#69010c050c074705080406071d2901011a470e061f"><span class="__cf_email__" data-cfemail="a9c1ccc5ccc787c5c8c4c6c7dde9c1c1da87cec6df">[email protected]</span></a>. Note: The meeting will be available to the public 
live at www.hhs.gov/live.

[[Page 316]]


SUPPLEMENTARY INFORMATION: Notice of these meetings is given under the 
Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)(1) and 
(a)(2)). Topics of the Meeting: Impact of COVID-19 on people with 
dementia, health disparities in dementia research, and the implications 
of new technologies to identify Alzheimer's disease through a blood 
tests.
    Procedure and Agenda: The meeting will be webcast at www.hhs.gov/live and video recordings will be added to the National Alzheimer's 
Project Act website when available, after the meeting.

    Authority: 42 U.S.C. 11225; Section 2(e)(3) of the National 
Alzheimer's Project Act. The panel is governed by provisions of 
Public Law 92-463, as amended (5 U.S.C. Appendix 2), which sets 
forth standards for the formation and use of advisory committees.

    Dated: December 21, 2020.
Brenda Destro,
Deputy Assistant Secretary for Planning and Evaluation, Office of Human 
Services Policy.
[FR Doc. 2020-29141 Filed 1-4-21; 8:45 am]
BILLING CODE 4150-05-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>